In late 2017, we learned that patent trolls (especially pharma patent gougers) were paying US Native Indian tribes to act as fronts for them in order to block review and cancellation of bogus patents -- the tribes have a treaty right to "sovereign immunity," which protects them from some forms of litigation.
Read the rest
In September, we learned that the pharma giant Allergan had sold key patents to the St Regis Mohawk band in upstate New York, in a bid to avoid a streamlined patent-challenge process called inter partes review (IPR). Read the rest
A couple weeks ago, we learned that pharma giant Allergan had transferred title to its most profitable eye drugs to New York's St Regis Mohawk band in order to invoke the band's "sovereign immunity" in proceedings that sought to invalidate its patents and make its drugs universally available at low costs. Read the rest